P527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) - SAFETY, EFFICACY AND PK/PD IN THE FIRST TWO COHORTS
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844996.76777.9b |
| _version_ | 1797287914827153408 |
|---|---|
| author | Y. Liu O. M. Bah D. Bollino K. Caprinolo J. Zarrabi S. Philip R. G. Lapidus E. T. Strovel Z. N. Singh M. E. Kallen Y. Ning R. Koka S. Niyongere V. H. Duong M. R. Baer M. Graveno A. Emadi |
| author_facet | Y. Liu O. M. Bah D. Bollino K. Caprinolo J. Zarrabi S. Philip R. G. Lapidus E. T. Strovel Z. N. Singh M. E. Kallen Y. Ning R. Koka S. Niyongere V. H. Duong M. R. Baer M. Graveno A. Emadi |
| author_sort | Y. Liu |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:44Z |
| format | Article |
| id | doaj.art-965f3cf368dd46a9ab85f8dcbaccfab6 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:44Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-965f3cf368dd46a9ab85f8dcbaccfab62024-03-02T03:51:50ZengWileyHemaSphere2572-92412022-06-01642642710.1097/01.HS9.0000844996.76777.9b202206003-00426P527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) - SAFETY, EFFICACY AND PK/PD IN THE FIRST TWO COHORTSY. Liu0O. M. Bah1D. Bollino2K. Caprinolo3J. Zarrabi4S. Philip5R. G. Lapidus6E. T. Strovel7Z. N. Singh8M. E. Kallen9Y. Ning10R. Koka11S. Niyongere12V. H. Duong13M. R. Baer14M. Graveno15A. Emadi161 University of Maryland Greenebaum Comprehensive Cancer Center1 University of Maryland Greenebaum Comprehensive Cancer Center1 University of Maryland Greenebaum Comprehensive Cancer Center1 University of Maryland Greenebaum Comprehensive Cancer Center1 University of Maryland Greenebaum Comprehensive Cancer Center1 University of Maryland Greenebaum Comprehensive Cancer Center1 University of Maryland Greenebaum Comprehensive Cancer Center2 Pediatrics3 Pathology, University of Maryland School of Medicine, Baltimore, United States of America3 Pathology, University of Maryland School of Medicine, Baltimore, United States of America3 Pathology, University of Maryland School of Medicine, Baltimore, United States of America3 Pathology, University of Maryland School of Medicine, Baltimore, United States of America1 University of Maryland Greenebaum Comprehensive Cancer Center1 University of Maryland Greenebaum Comprehensive Cancer Center1 University of Maryland Greenebaum Comprehensive Cancer Center1 University of Maryland Greenebaum Comprehensive Cancer Center1 University of Maryland Greenebaum Comprehensive Cancer Centerhttp://journals.lww.com/10.1097/01.HS9.0000844996.76777.9b |
| spellingShingle | Y. Liu O. M. Bah D. Bollino K. Caprinolo J. Zarrabi S. Philip R. G. Lapidus E. T. Strovel Z. N. Singh M. E. Kallen Y. Ning R. Koka S. Niyongere V. H. Duong M. R. Baer M. Graveno A. Emadi P527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) - SAFETY, EFFICACY AND PK/PD IN THE FIRST TWO COHORTS HemaSphere |
| title | P527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) - SAFETY, EFFICACY AND PK/PD IN THE FIRST TWO COHORTS |
| title_full | P527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) - SAFETY, EFFICACY AND PK/PD IN THE FIRST TWO COHORTS |
| title_fullStr | P527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) - SAFETY, EFFICACY AND PK/PD IN THE FIRST TWO COHORTS |
| title_full_unstemmed | P527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) - SAFETY, EFFICACY AND PK/PD IN THE FIRST TWO COHORTS |
| title_short | P527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) - SAFETY, EFFICACY AND PK/PD IN THE FIRST TWO COHORTS |
| title_sort | p527 phase 1 trial of pegcrisantaspase in combination with venetoclax in adults with relapsed or refractory acute myeloid leukemia r r aml safety efficacy and pk pd in the first two cohorts |
| url | http://journals.lww.com/10.1097/01.HS9.0000844996.76777.9b |
| work_keys_str_mv | AT yliu p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT ombah p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT dbollino p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT kcaprinolo p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT jzarrabi p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT sphilip p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT rglapidus p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT etstrovel p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT znsingh p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT mekallen p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT yning p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT rkoka p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT sniyongere p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT vhduong p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT mrbaer p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT mgraveno p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts AT aemadi p527phase1trialofpegcrisantaspaseincombinationwithvenetoclaxinadultswithrelapsedorrefractoryacutemyeloidleukemiarramlsafetyefficacyandpkpdinthefirsttwocohorts |